A dermal filler for volumised, natural looking and ‘kissable’ lips, backed by science.
When it comes to facial injectables, lip enhancement with hyaluronic acid (HA) fillers remains a highly popular procedure and is often subject to celebrity-driven ‘trends’ for a particular look or shape. In recent years, consumer demand has shifted away from the highly exaggerated effect of Angelina Jolie or Kylie Jenner to a more understated, natural-looking result. This reflects the ethos of many reputable practitioners, who prefer to subtly enhance and augment patients’ lips with a versatile, carefully designed product such as Restylane Kysse – which restores youthful volume whilst retaining a natural look and feel – both in dynamic and resting expressions.
Restylane Kysse for movement and volume
Restylane Kysse from Galderma is designed for flexible movement and natural-looking volume proven to last for up to one year.1,2,3 The OBT™ technology produces soft and flexible gels, helping create a natural fullness and volume not only at rest but also in animation. The softness and flexibility of the HA gel is tailored to ensure sufficient firmness to retain the desired lip shape over time.
Provides patient and partner satisfaction
A key concern among patients considering lip enhancement is not only achieving a natural look and feel post-treatment, but also how their partners will find the result. Galderma can now provide additional confidence and reassurance for practitioners, thanks to results from an open-label post-marketing study of 59 patients, which assessed both patient and partner satisfaction following treatment with Restylane Kysse:
· 100% of patients and investigators rated lips as improved, much improved or very much improved at week eight post-treatment.
• 87% of patients felt more attractive.
• 98% of patients were satisfied or very satisfied with the kissability of their lips.
• 96% thought that their lips had a natural look after treatment.
In addition, 90% of the partners were satisfied or very satisfied with the appearance of the patients’ lips after treatment and 73% of partners agreed that the patients’ lips had a more kissable and natural feel after treatment.
*Study information: 19 patients received Restylane Kysse only, and 40 received Restylane Kysse in combination with Restylane Refyne and/or Restylane Defyne for correction of facial wrinkles and folds. Regarding safety, all treatment-emergent related adverse events were non-serious and 96% were mild, with a median duration of 2.5 days. In other words, treatment with Restylane Kysse in the lips was well tolerated.1
Explore the Restylane portfolio
To find out more about Restylane Kysse and how this can complement your treatment portfolio, speak to your Galderma sales representative or contact sales.UK@galderma.com.
Adverse events should be reported
For the UK, reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or App Store.
For Ireland, suspected adverse events can be reported via HPRA Pharmacovigilance, www.hpra.ie
Adverse events should also be reported to Galderma (UK) Ltd.